GB2139617B - New cephem compounds and processes for preparation thereof - Google Patents

New cephem compounds and processes for preparation thereof

Info

Publication number
GB2139617B
GB2139617B GB08331713A GB8331713A GB2139617B GB 2139617 B GB2139617 B GB 2139617B GB 08331713 A GB08331713 A GB 08331713A GB 8331713 A GB8331713 A GB 8331713A GB 2139617 B GB2139617 B GB 2139617B
Authority
GB
United Kingdom
Prior art keywords
processes
preparation
cephem compounds
new cephem
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08331713A
Other languages
English (en)
Other versions
GB8331713D0 (en
GB2139617A (en
Inventor
Takao Takaya
Takashi Masugi
Hisashi Takasugi
Hideaki Yamnaka
Takashi Odino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838300122A external-priority patent/GB8300122D0/en
Priority claimed from GB838317496A external-priority patent/GB8317496D0/en
Priority claimed from GB838329768A external-priority patent/GB8329768D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of GB8331713D0 publication Critical patent/GB8331713D0/en
Publication of GB2139617A publication Critical patent/GB2139617A/en
Application granted granted Critical
Publication of GB2139617B publication Critical patent/GB2139617B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
GB08331713A 1982-12-06 1983-11-28 New cephem compounds and processes for preparation thereof Expired GB2139617B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8234755 1982-12-06
GB838300122A GB8300122D0 (en) 1983-01-05 1983-01-05 Cephem compounds
GB838317496A GB8317496D0 (en) 1983-06-28 1983-06-28 Cephem compounds
GB838329768A GB8329768D0 (en) 1983-11-08 1983-11-08 Cephem compounds

Publications (3)

Publication Number Publication Date
GB8331713D0 GB8331713D0 (en) 1984-01-04
GB2139617A GB2139617A (en) 1984-11-14
GB2139617B true GB2139617B (en) 1986-09-24

Family

ID=27449416

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08331713A Expired GB2139617B (en) 1982-12-06 1983-11-28 New cephem compounds and processes for preparation thereof

Country Status (17)

Country Link
US (2) US4584290A (enExample)
EP (1) EP0111281B1 (enExample)
JP (1) JPH0639475B2 (enExample)
KR (1) KR840007011A (enExample)
AU (1) AU2174783A (enExample)
CH (1) CH656882A5 (enExample)
DE (1) DE3381627D1 (enExample)
DK (1) DK554483A (enExample)
ES (3) ES8506729A1 (enExample)
FI (1) FI834413A7 (enExample)
FR (1) FR2537141B1 (enExample)
GB (1) GB2139617B (enExample)
GR (1) GR79043B (enExample)
IT (1) IT1168734B (enExample)
NO (1) NO834463L (enExample)
OA (1) OA07602A (enExample)
PT (1) PT77772B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79043B (enExample) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co
WO1994006804A1 (fr) * 1992-09-18 1994-03-31 Otsuka Kagaku Kabushiki Kaisha Compose de cepheme, son procede de production et medicament le contenant
US5698544A (en) * 1994-03-17 1997-12-16 Otsuka Kagaku Kabushiki Kaisha Cephem compound, process for producing the compound, and antimicrobial composition containing the same
AU4496896A (en) * 1995-01-30 1996-08-21 Takeda Chemical Industries Ltd. Cephem compounds, their production and use
AU5781396A (en) * 1995-05-29 1996-12-18 Takeda Chemical Industries Ltd. Cephem compounds, their production and use
AU707822B2 (en) * 1995-07-13 1999-07-22 Koninklijke Philips Electronics N.V. Method and system for data repetition between logically successive clusters
MY127641A (en) * 1995-10-12 2006-12-29 Essential Therapeutics Inc Cephalosporin antibiotics
US6025352A (en) * 1997-09-29 2000-02-15 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
US6030965A (en) * 1997-09-30 2000-02-29 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
AUPO973297A0 (en) * 1997-10-10 1997-11-06 Fujisawa Pharmaceutical Co., Ltd. New compound
EP1478649A4 (en) * 2002-02-28 2006-09-13 Lg Life Sciences Ltd NOVEL CEPHALOSPORINE-BASED COMPOUNDS AND METHOD OF MANUFACTURING THE SAME
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN104177408B (zh) * 2014-09-12 2016-09-07 衡水衡林生物科技有限公司 （z）-2-(5-二氯磷酰氨基-1,2,4-噻二唑-3-基)-2-乙氧亚胺基乙酰氯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193798A (en) * 1979-05-23 1983-11-18 Rhone Poulenc Ind 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
FR2494280A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine et leur preparation
FR2494274A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
GR79043B (enExample) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
DE3381627D1 (de) 1990-07-12
PT77772A (en) 1984-01-01
DK554483A (da) 1984-06-07
IT1168734B (it) 1987-05-20
IT8324035A0 (it) 1983-12-05
US4584290A (en) 1986-04-22
EP0111281B1 (en) 1990-06-06
ES8505690A1 (es) 1985-06-01
EP0111281A2 (en) 1984-06-20
ES527790A0 (es) 1985-07-16
GB8331713D0 (en) 1984-01-04
US4719206A (en) 1988-01-12
GR79043B (enExample) 1984-10-02
ES534203A0 (es) 1985-07-16
FI834413A7 (fi) 1984-06-07
ES8506729A1 (es) 1985-07-16
CH656882A5 (de) 1986-07-31
KR840007011A (ko) 1984-12-04
FR2537141B1 (fr) 1987-02-27
FI834413A0 (fi) 1983-12-02
OA07602A (fr) 1985-03-31
JPH0639475B2 (ja) 1994-05-25
NO834463L (no) 1984-06-07
GB2139617A (en) 1984-11-14
EP0111281A3 (en) 1985-07-03
JPS59130292A (ja) 1984-07-26
PT77772B (en) 1986-04-17
AU2174783A (en) 1984-06-14
ES534202A0 (es) 1985-06-01
FR2537141A1 (fr) 1984-06-08
ES8506730A1 (es) 1985-07-16
DK554483D0 (da) 1983-12-01

Similar Documents

Publication Publication Date Title
GB2128990B (en) New cephem compounds and processes for preparation thereof
GB2144420B (en) New cephem compounds and processes for preparation thereof
DE3368047D1 (en) Process for the preparation of p-nitrosodiphenylamine
EP0111281A3 (en) New cephem compounds and processes for preparation thereof
EP0223246A3 (en) New cephem compounds and processes for preparation thereof
CY1470A (en) Process for the preparation of phenylalkylaminoethylsalicylamide
DE3277534D1 (en) New cephem compounds and processes for preparation thereof
EP0099553A3 (en) New cephem compounds and processes for preparation thereof
DE3172904D1 (en) New cephem compounds and processes for preparation thereof
DE3176111D1 (en) New cephem compounds and processes for preparation thereof
DE3175156D1 (en) New cephem compounds and processes for preparation thereof
DE3274548D1 (en) New cephem compounds and processes for preparation thereof
GB2130582B (en) New cephem compounds and processes for preparation thereof
GB2148890B (en) New cephem compounds and processes for preparation thereof
ZA813787B (en) New cephem compounds and processes for preparation thereof
DE3170463D1 (en) New cephem compounds and processes for preparation thereof
ZA806068B (en) Cephem compounds and processes for preparation thereof
DE3372479D1 (en) Process for the preparation of 4-chloro-2-nitrobenzonitrile
DE3362429D1 (en) Process for the preparation of thiadiazoloxyacetamides
DE3367912D1 (en) Process for the preparation of n-allyl-o-alkyl-thioncarbamates
DE3360384D1 (en) Process for the preparation of 1-hydroxyketones
DE3361356D1 (en) Process for the preparation of 3-acylaminoanilines
ZA835850B (en) Ergot alcaloids
DE3365382D1 (en) Process for the preparation of 2-chlorobenzoxazols
ZA823722B (en) New cephem compounds and processes for preparation thereof

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19951128